Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19.
Enrique J. deAndrés-GalianaJuan Luis Fernández MartínezÓscar Álvarez-MachancosesGuillermina BeaCarlos M. GalmariniAndrzej KloczkowskiPublished in: Comput. Biol. Medicine (2022)